Biospecimen Strategy & Logistics
Quick Answer
We design and implement comprehensive biospecimen management strategies that ensure sample integrity, data quality, and regulatory compliance. From protocol development to vendor selection and ongoing oversight, we help you avoid the costly mistakes that compromise biomarker endpoints and delay trial timelines.
The Challenge
Biospecimen management is one of the most complex and high-risk aspects of clinical trials, yet it's often treated as an afterthought. Poor planning leads to inadequate sample volumes, compromised sample integrity, missing data, and failed biomarker endpoints - any of which can derail your entire program.
Common issues include collection protocols that don't account for real-world site capabilities, processing timelines that compromise analyte stability, inadequate chain-of-custody documentation, and vendor laboratories that lack the specialized capabilities your assays require. These problems often don't surface until you're deep into the trial, when corrective actions are costly, and data loss is irreversible.
Small biotech companies face unique challenges: limited experience with complex biospecimen logistics, pressure to minimize costs, and the need to make critical vendor decisions without a full understanding of the trade-offs. The result is often a biospecimen strategy that looks good on paper but fails in execution.
How It Works
01
Protocol Review & Strategy Development
We review your protocol and biomarker objectives to develop a comprehensive biospecimen strategy. This includes collection schedules, sample types and volumes, processing requirements, storage conditions, and shipping logistics. We can also work together with your team to sharpen & finetune your study's biomarker plan.
02
Vendor Selection & Qualification
We help you select and qualify laboratories, biorepositories, and logistics providers. This includes developing RFPs, evaluating capabilities, conducting site visits, and negotiating contracts that protect your interests.
03
Procedure Development
We develop detailed collection, processing, and shipping procedures that are practical for sites to implement. This includes laboratory manuals, site training materials, and troubleshooting guides. We can guide your central laboratory to set up systems that are most suitable for your study.
04
Implementation & Training
We support trial startup activities including vendor onboarding, site training, and kit preparation. We ensure all parties understand their responsibilities and have the tools they need to succeed.
05
Ongoing Oversight & Troubleshooting
We provide ongoing monitoring of biospecimen operations, including data review, vendor performance tracking, and rapid response to issues. We identify problems early and implement corrective actions before they impact your endpoints.
What's Included
Biospecimen strategy development
Laboratory and biorepository selection
Collection and processing procedure development
Site training materials and delivery
Chain-of-custody system design
Ongoing vendor oversight and monitoring
Protocol review and optimization
Vendor qualification and auditing
Laboratory manual creation
Kit design and logistics planning
Data management and tracking systems
Issue investigation and resolution
Who It's For
This service is essential for small biotech companies conducting trials with biomarker endpoints, pharmacokinetic/pharmacodynamic assessments, or exploratory biospecimen collection.
It's particularly valuable for sponsors working with novel biomarkers, complex sample types (e.g., tissue, CSF, rare cells), or multi-site global trials where logistics and standardization are critical. Whether you're planning your first trial with biospecimen collection or troubleshooting issues in an ongoing program, we provide the specialized expertise to ensure your biospecimen strategy supports your scientific objectives and regulatory requirements.
Frequently Asked Questions
Ideally, during protocol development, before you finalize your biospecimen collection schedule and endpoints. Early engagement allows us to optimize your strategy from the start. However, we can also help troubleshoot existing programs experiencing data quality issues or vendor challenges.
Yes, we conduct comprehensive vendor assessments, develop RFPs, evaluate proposals, and support contract negotiations. We have extensive experience with both specialized biorepositories and large laboratory networks.
We partner with your scientific team to design a biomarker strategy tailored to your therapeutic area — aligning collection, processing, and analysis plans with the endpoints that matter most. The result: an endpoint framework that strengthens your regulatory submission, operationalizes your protocol, and protects your runway.
We conduct rapid assessments to identify root causes and implement corrective actions. This may include retraining sites, revising procedures, changing vendors, or implementing additional quality controls. Our goal is to minimize data loss and prevent future issues.
Yes, we offer flexible engagement models including ongoing oversight, periodic audits, and on-demand support for issues that arise during the trial. We can also train your internal team to manage biospecimen operations independently.